{
  "title": "Paper_635",
  "abstract": "pmc J Biomed Res J Biomed Res 1958 jbr J Biomed Res Journal of Biomedical Research 1674-8301 2352-4685 Education Department of Jiangsu Province PMC12481670 PMC12481670.1 12481670 12481670 41024611 10.7555/JBR.39.20250800 JBR-editorial-commentary-2025-39-5 1 Editorial Commentary Editorial commentary on the special issue of cancer research Board Editorial 9 2025 39 5 497987 439 440 01 09 2025 01 10 2025 01 10 2025 Â© 2025 by Journal of Biomedical Research. https://creativecommons.org/licenses/by/4.0/ This is an open access article under the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. pmc-status-qastatus 0 pmc-status-live yes pmc-status-embargo no pmc-status-released yes pmc-prop-open-access yes pmc-prop-olf no pmc-prop-manuscript no pmc-prop-legally-suppressed no pmc-prop-has-pdf yes pmc-prop-has-supplement no pmc-prop-pdf-only no pmc-prop-suppress-copyright no pmc-prop-is-real-version no pmc-prop-is-scanned-article no pmc-prop-preprint no pmc-prop-in-epmc yes Cancer remains one of the leading causes of mortality worldwide, with its complex etiology and heterogeneous progression posing persistent challenges to early diagnosis and effective treatment. In this special issue, we present a collection of studies that delve into the molecular mechanisms, therapeutic resistance, and novel treatment strategies across multiple cancer types, including lung, breast, stomach, and liver cancers. These studies not only advance our understanding of tumor biology but also provide translational insights with potentially significant clinical implications. Wang et al [ 1 In the context of targeted therapy resistance, Lyu et al [ 2 Sun et al [ 3 Huo et al [ 4 via In gastric cancer research, Han et al [ 5 DDR1 via DDR1 Boonto et al [ 6 TUG1 TUG1 In a letter to the editor, Vats et al [ 7 Kakurina et al [ 8 Collectively, the studies in this issue illustrate the multifaceted nature of cancer biology and the importance of integrating molecular, clinical, and epidemiological approaches. From endocrine-cancer interactions to resistance mechanisms and metastatic progression, these contributions advance our knowledge and open new avenues for precision oncology. We hope this special issue will inspire further research and foster translational efforts aimed at improving cancer diagnosis, treatment, and patient outcomes. We extend our gratitude to the authors, reviewers, and editorial team for their invaluable contributions to this issue. Ducument code: A The authors reported no conflict of interests. References 1 Wang X, Wang X, Zhao M, et al Bidirectional Mendelian randomization and mediation analysis of million-scale data reveal causal relationships between thyroid-related phenotypes, smoking, and lung cancer J Biomed Res 2025 39 5 441 451 10.7555/JBR.38.20240421 40065519 PMC12481675 2 Lyu L, Hua X, Liu J, et al Anlotinib reverses osimertinib resistance by inhibiting epithelial-to-mesenchymal transition and angiogenesis in non-small cell lung cancer J Biomed Res 2025 39 5 452 466 10.7555/JBR.38.20240045 PMC12481689 39375945 3 Sun R, Zong D, Chen X, et al The effects and toxicity profiles of consolidative and salvage thoracic radiotherapy following chemoimmunotherapy in patients with extensive-stage small cell lung cancer J Biomed Res 2025 39 5 467 477 10.7555/JBR.39.20250067 40420608 PMC12481674 4 Huo Y, Chen K, Qiang Z, et al DEC1 promotes breast cancer bone metastasis through transcriptional activation of CXCR4 J Biomed Res 2025 39 5 478 499 10.7555/JBR.39.20250031 40420604 PMC12481698 5 Han H, Shen T, Zhou T, et al Overexpression of DDR1 J Biomed Res 2025 39 5 500 514 10.7555/JBR.39.20250198 40456688 PMC12481679 6 Boonto T, Phetkong C, Ariyachet C Long non-coding RNA TUG1 J Biomed Res 2025 39 5 515 529 10.7555/JBR.39.20250056 40696822 PMC12481678 7 Vats P, Nirmal S, Kumar A, et al Chromosomal passenger complex-cyclin/CDK axis correlated with poor lung cancer prognosis J Biomed Res 2025 39 5 530 533 10.7555/JBR.38.20240296 39930665 PMC12481672 8 Kakurina GV, Sereda EE, Stakheeva MN, et al The serum fascin-1 and tumor components containing this protein in patients with head and neck squamous cell carcinoma: A pilot study J Biomed Res 2025 39 5 534 537 10.7555/JBR.38.20240397 40669873 PMC12481671 ",
  "metadata": {
    "Title of this paper": "The serum fascin-1 and tumor components containing this protein in patients with head and neck squamous cell carcinoma: A pilot study",
    "Journal it was published in:": "Journal of Biomedical Research",
    "URL": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12481670/"
  }
}